Jennifer Chang

Vp, Financial Planning & Analysis at Vir Biotechnology

Jennifer Chang has a diverse work experience spanning over 14 years. Jennifer is currently working at Vir Biotechnology, Inc. as the VP of Financial Planning & Analysis since March 2022. Prior to this, they held various roles at Vir Biotechnology, including Senior Director, Director, and Associate Director of Finance Planning & Analysis.

Before joining Vir Biotechnology, Jennifer worked at Depomed, Inc. from 2011 to 2017. Jennifer started as a Senior Financial Analyst and progressed to the role of Associate Director of Finance.

Jennifer also has experience as a Financial Analyst at XenoPort, an Analyst at Paul Capital Partners, and an Equity Research Associate Intern at New Vernon Associates.

Additionally, Jennifer has worked as a Teaching Assistant at UC Berkeley Haas Business School and as an Undergraduate Research Assistant at Lawrence Berkeley National Lab.

Overall, Jennifer Chang has a strong background in finance and planning, with experience in various leadership positions and industries.

Jennifer Chang earned a Bachelor of Science (BS) degree in Business Administration from the University of California, Berkeley, Haas School of Business from 2007 to 2009. In addition, they obtained a Bachelor of Arts (BA) degree in Molecular and Cell Biology from the University of California, Berkeley from 2006 to 2009. Prior to that, they earned a High School Diploma from The Lawrenceville School in 2005 and Taipei First Girl's Senior High in 2004, with a field of study specialization in Science.

Links

Previous companies

Xenoport logo

Timeline

  • Vp, Financial Planning & Analysis

    March, 2022 - present

  • Senior Director, Fp&a

    March, 2020

  • Director, Finance Planning And Analysis

    January, 2019

  • Associate Director, Fp&a

    October, 2017

View in org chart